NeoMedSys – end-to-end AI-model development platform for radiology

Business Opportunity

NeoMedSys is a scalable software platform for CT and MR image analysis, integrating AI/ML deployment, data analytics, and secure database management in one user-friendly system. Developed at Rikshospitalet’s CRAI group, it is in closed beta and already supporting multiple Inven2-backed projects. The first target market is research institutions, where workflows rely on disconnected tools and manual data transfers. NeoMedSys enables seamless AI model development and evaluation within a PACS connected environment. The platform has potential to extend into clinical use for regulatory-approved diagnostics. Competition from PACS vendors (Siemens, Philips, Sectra) and cloud players (DeepC, Incepto) is limited to approved clinical models, leaving the research segment underserved. NeoMedSys addresses this gap, creating early-mover advantage and customer relationships that can bridge into clinical markets. The technology is planned to spin-out with a committed founding team in 2026. Near-term goals include a release candidate, compliance audits, regulatory strategy, and market validation. Looking for partners and investors: We seek strategic partners and early-stage investors for pilot projects, co-development, and financing.

Technology Description

NeoMedSys is an advanced medical intelligence platform that seamlessly integrates machine learning, data analytics, and database management into a scalable, user-friendly system designed to empower healthcare professionals and researchers. The technology has already achieved TRL 5, with demonstrated success in supporting innovative research projects such as BodySegAI, CHRONOS, and brain bleed measurement VB-AI within Norwegians biggest hospital environment. NeoMedSys addresses key challenges in healthcare and medical research. By enabling the efficient training and deployment of AI models with built-in standards, traceability, and reproducibility, it significantly enhances the quality of medical research. For clinicians, NeoMedSys facilitates unprecedented insights, such as voxel-based 3D statistical analysis and automated time-series comparisons, which current systems fail to deliver. This drastically improves precision medicine, empowering doctors to provide deeper, patient-specific analyses without spending excessive time on manual processes. Uniquely collaborative, NeoMedSys breaks down organizational silos, enabling seamless cooperation between researchers, oncologists, pathologists, and radiologists. By offering a centralized platform for sharing work, data, and AI models, it becomes a launch pad for an AI-powered medical community. Unlike current PACS or similar systems, NeoMedSys introduces unmatched capabilities tailored specifically for modern, AI-driven healthcare. The platform’s ultimate vision is to extend its application to clinical environments, facilitating the deployment of regulatory-approved machine learning models for improved diagnostics and more personalized patient care. If you want to know more, here you can find more information about Neomedsys: https://www.neomedsys.io/

Fig. 1: A powerful platform with user-friendly interface

Intellectual Property